Pablo Corral Shares Insights on Remnant Cholesterol and Its Role in Atherosclerotic Cardiovascular Disease
Pablo Corral, Past President of Argentine Lipid Society, has shared a post on LinkedIn:
“A significant presence in atherosclerotic cardiovascular disease: Remnant cholesterol: A review
Remnant cholesterol: the overlooked driver of residual risk in ASCVD
Despite achieving LDL-C targets with statins and novel lipid-lowering therapies, patients remain exposed to substantial residual cardiovascular risk. Emerging evidence highlights remnant cholesterol (RC)—the cholesterol content of triglyceride-rich lipoproteins—as a causal factor in atherosclerosis.
Epidemiological, genetic, and mechanistic studies consistently show that elevated RC predicts major adverse cardiovascular events, independently of LDL-C. Mendelian randomization confirms a causal role, while clinical data suggest that RC promotes endothelial dysfunction, inflammation, and thrombosis.
Although lifestyle interventions remain essential, pharmacologic strategies—including statins, fibrates, PCSK9 inhibitors, and novel gene-targeted therapies—can reduce RC levels. However, standardized measurement and clear therapeutic targets are still lacking.
RC should be recognized as a priority marker in cardiovascular prevention, guiding future strategies to reduce residual risk in high-risk populations”
Title: A significant presence in atherosclerotic cardiovascular disease: Remnant cholesterol: A review
Authors: Li Wang, Qingmei Zhang, Zhiyang Wu, Xiwei Huang
Read the full article here.
Stay informed with Hemostasis Today.
-
Oct 14, 2026, 20:36How Does Inflammation Reshape Red Blood Cell Production? – ASH
-
Oct 14, 2026, 20:30Marilena Vrana: Putting Faces to the Chain – Donors and Patients Connect in Milan for IPAW 2026
-
Oct 14, 2026, 20:25Asim Alam: Hillsborough County and Partners Demonstrate Drone-Based Emergency Blood Delivery
-
Oct 14, 2026, 20:19Zahid Khanzada: 3rd Position in the Hematology Quiz at PCUH
-
Oct 14, 2026, 20:14Samiul Bashir: The 47th Recognized System in Transfusion Medicine
-
Oct 14, 2026, 20:06Mavis Agnes Kisakye: Petition Advocating for Enhanced Haemophilia Care Presented to EALA Parliament
-
Oct 14, 2026, 20:03Sheharyar Raza: What Are Ways AI and ML Are Impacting How We Collect and Transfuse Blood?
-
Oct 14, 2026, 19:58Alessandro Lucchesi: Three Minutes of RiseMPN 2025
-
Oct 14, 2026, 19:55Talha Waseem: HbA1c – What Does Its Name Actually Mean?